# Michigan Marijuana Industry Files Second Lawsuit Over 24% Tax > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/michigan-marijuana-tax-lawsuit-challenge/ > **Published:** 2026-03-30T18:13:42-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:34:40-04:00 > **Clinical Summary:** Michigan marijuana tax lawsuit challenges the 24% excise tax affecting patient access and industry growth in the cannabis market. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic AccessPolicyPatient Cost[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)Healthcare Economics Why This Matters Tax policy directly affects patient access to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/), particularly for chronic conditions requiring sustained treatment. High excise taxes can drive patients toward unregulated products or discontinuation of effective therapies. Clinical Summary Michigan’s cannabis industry has filed a second lawsuit challenging the state’s 24% excise tax structure. The industry argues this tax burden creates barriers to legal cannabis access and may push consumers toward illicit markets. Tax policy represents a significant factor in [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) accessibility, as patients often pay out-of-pocket without insurance coverage. Dr. Caplan’s Take “I see patients regularly forced to choose between their [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and other necessities because of cost barriers. When tax policy makes legal cannabis prohibitively expensive, we’re essentially rationing medicine based on economic status.” Clinical Perspective 🧠 Clinicians should be aware that high cannabis taxes may affect treatment adherence and patient decisions about product sourcing. Consider discussing cost concerns openly with patients and exploring dosing strategies that optimize therapeutic benefit while managing expense. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Michigan%20marijuana%20industry%20files%20second%20lawsuit%20over%2024%25%20tax%20-%20The%20Detroit%20News%20%40drcaplan&url=https%3A//www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Michigan%20marijuana%20industry%20files%20second%20lawsuit%20over%2024%25%20tax%20-%20The%20Detroit%20News%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/](https://www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What key areas does this cannabis news cover?](#What_key_areas_does_this_cannabis_news_cover) - [Why is this news considered clinically significant?](#Why_is_this_news_considered_clinically_significant) - [How does this relate to patient access and costs?](#How_does_this_relate_to_patient_access_and_costs) - [What should healthcare providers take away from this news?](#What_should_healthcare_providers_take_away_from_this_news) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This means it contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What key areas does this cannabis news cover? The article covers multiple important aspects including patient access, policy changes, patient costs, and medical cannabis regulations. These topics are particularly relevant for clinicians working with medical cannabis patients. #### Why is this news considered clinically significant? The news is classified as having notable clinical interest due to emerging findings or policy developments in the cannabis space. Such developments can directly impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/), treatment options, and clinical practice guidelines. #### How does this relate to patient access and costs? The article addresses both patient access to medical cannabis and associated costs, which are critical factors in treatment decisions. These elements significantly influence patient compliance and treatment outcomes in medical [cannabis therapy](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/). #### What should healthcare providers take away from this news? Healthcare providers should closely monitor these developments as they may affect prescribing practices, patient access, and treatment costs. Staying informed about policy changes helps ensure optimal [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and compliance with evolving regulations. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Michigan marijuana industry files second lawsuit over 24% tax – The Detroit News”, “url”: “https://www.detroitnews.com/story/news/politics/2026/03/30/marijuana-groups-escalate-fight-against-michigan-tax-structure/89387683007/”, “datePublished”: “2026-03-30T19:01:41Z”, “about”: “michigan marijuana industry files second lawsuit”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Michigan marijuana industry files another lawsuit to stop 24% wholesale tax – YouTube](https://cedclinic.com/michigan-marijuana-wholesale-tax-lawsuit/) Watch the latest updates on Michigan's cannabis industry's legal battle against the 24% wholesale tax affecting patient access and market growth. [Watch Now](https://cedclinic.com/michigan-marijuana-wholesale-tax-lawsuit/) [Cannabis group files second suit over Michigan pot tax – Spectrum News](https://cedclinic.com/michigan-cannabis-tax-lawsuit-second-suit/) Read about the second lawsuit filed by cannabis groups challenging Michigan's excise tax and its impact on patients and businesses. [Read More](https://cedclinic.com/michigan-cannabis-tax-lawsuit-second-suit/) [High costs block sick patients from medical cannabis – Scrolla. Africa](https://cedclinic.com/medical-cannabis-pricing-barriers-limit-patient-access/) Explore how high cannabis taxes and costs create barriers for patients needing [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/). [Learn More](https://cedclinic.com/medical-cannabis-pricing-barriers-limit-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).